Our Clinical Trials system is temporarily offline. Sorry for any inconvenience this may cause.
NCT ID | Study Title | Action |
---|---|---|
NCT06574373 | Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression | View |
NCT06108531 | Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer | View |
NCT05934331 | A LM-302 Combined With Toripalimab Phase II Study | View |
NCT02723331 | Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates | View |
NCT00602082 | Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors | View |
NCT00826982 | Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer | View |
NCT03788382 | Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer | View |
NCT01522573 | T-EUS for Gastrointestinal Disorders: A Multicenter Registry | View |
NCT04581473 | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection | View |
NCT00664482 | A Single-Patient Study Using AGS 006 | View |
NCT02706782 | A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma | View |
NCT01569282 | Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer | View |
NCT03114631 | Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer | View |
NCT04616131 | Evaluating the Response to Neoadjuvant Chemotherapy With Circulating Tumor DNA in Pancreatic Cancer | View |
NCT02595931 | M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | View |
NCT02546531 | Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer | View |
NCT01333631 | Valproic Acid With Chemoradiotherapy for Pancreatic Cancer | View |
NCT02685631 | Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study | View |
NCT00001431 | A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas | View |
NCT00837031 | Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas | View |
NCT02782182 | Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study | View |
NCT01726582 | Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") | View |
NCT01814631 | Endoscopic Ultrasound (EUS) Processor Comparison | View |
NCT02352831 | Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma | View |
NCT04494282 | The Economic Impact of the Pancreatography in the Endoscopic Treatment of Pancreatic Pseudocysts | View |
National Pancreatic Cancer Foundation provides access to clinical research studies. This information is provided by clinicaltrials.gov and is maintained by the National Library of Medicine (NLM). Neither NPCF nor the US government review or approve the safety and science of the studies on this website. Read the disclaimer for details.Â
NPCF was founded on May 29, 2009 and is a 501(c)(3) organization. All donations are tax deductible.
The information and services provided by the National Pancreatic Cancer Foundation are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. The National Pancreatic Cancer Foundation does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.
Copyright © 2024 – National Pancreatic Cancer Foundation | All Rights Reserved